These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33457006)

  • 1. Relationship between plasma cell-free DNA (cfDNA) and prognosis of TACE for primary hepatocellular carcinoma.
    Ma K; Liu J; Wang Y; Zhong Y; Wu Z; Fan R; Guo S
    J Gastrointest Oncol; 2020 Dec; 11(6):1350-1363. PubMed ID: 33457006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum TSGF and miR-214 levels in patients with hepatocellular carcinoma and their predictive value for the curative effect of transcatheter arterial chemoembolization.
    Tang L; Zhang XM
    Ann Palliat Med; 2020 Jul; 9(4):2111-2117. PubMed ID: 32762227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
    Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
    Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous microwave ablation and transcatheter arterial chemoembolization for serum tumor markers and prognostics of middle-late primary hepatic carcinoma.
    Lin ZP; Huang DB; Zou XG; Chen Y; Li XQ; Zhang J
    World J Gastrointest Surg; 2023 Dec; 15(12):2783-2791. PubMed ID: 38222024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of GP73 in primary hepatocellular carcinoma and its function in the assessment of transcatheter arterial chemoembolization.
    Ai N; Liu W; Li ZG; Ji H; Li B; Yang G
    Oncol Lett; 2017 Oct; 14(4):3953-3958. PubMed ID: 28943903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
    Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
    J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free DNA as a biomarker for colorectal cancer: a retrospective analysis in patients before and after surgery.
    Zhong Y; Zhou Q; Zhang Y; Zhou S; Zhang G; Jiang C; Zhang Z; Zhang X; Xu J; Jin C; Cao L; Chen L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):135-141. PubMed ID: 32415940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatment.
    Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Chen Y; Zhang B; Zhu P
    Eur J Surg Oncol; 2022 Sep; 48(9):2014-2022. PubMed ID: 35595579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis.
    Liu X; Li H; Wang F; Su K; He B; He J; Zhong J; Han Y; Li Z
    BMC Gastroenterol; 2023 Sep; 23(1):299. PubMed ID: 37670232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma.
    Jun CH; Ki HS; Lee HK; Park KJ; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    World J Gastroenterol; 2013 Jan; 19(2):284-9. PubMed ID: 23345952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNA.
    Li Z; Xiao D; Li X; Zhan P; Wang J; Zhang H
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):885-892. PubMed ID: 30807446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a predictive model for short-term efficacy of transcatheter arterial chemoembolization treatment in hepatocellular carcinoma and its clinical application.
    Wei J; Wang Z
    J Cancer Res Ther; 2019; 15(4):941-946. PubMed ID: 31436256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical value of heat shock protein 90α in predicting the prognosis of interventional therapy for hepatocellular carcinoma].
    Sun W; Li X
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):118-126. PubMed ID: 38418185
    [No Abstract]   [Full Text] [Related]  

  • 15. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
    Liu G; Guo W; Wang H; Liu W; Lei L; Xie Q; Li X; Zou S; Wang P; Zhou H; Hu H
    Ann Palliat Med; 2021 Apr; 10(4):3673-3683. PubMed ID: 33691434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of plasma cell-free DNA combined with VEGF-C in laryngeal squamous cell carcinoma.
    Huang Q; Ji M; Li F; Li Y; Zhou X; Hsueh CY; Zhou L
    Mol Cell Probes; 2023 Feb; 67():101895. PubMed ID: 36682577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy.
    Chen ZH; Zhang XP; Cai XR; Xie SD; Liu MM; Lin JX; Ma XK; Chen J; Lin Q; Dong M; Wu XY; Wen JY; Xu RH
    J Cancer; 2018; 9(19):3467-3478. PubMed ID: 30310503
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.
    He K; Yang Z; Liu X; Yang Y; Song W; Wang S; Chen Y
    Curr Oncol; 2022 Dec; 30(1):476-491. PubMed ID: 36661687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.